Latest

With support from UCLPartners Aspiring Improvers programme, two junior doctors were able to establish resources to reduce stress and anxiety for trainees in paediatric emergencies.

SMEs and start-ups with healthtech products with the potential to support our health and care system often do not know how best to approach the NHS. Chris Wood of UCLPartners’ Commercial & Innovation team provides a quick tour through the complex and changing NHS landscape.

UCLPartners has been awarded an AF Association Healthcare Pioneer Award for work with South East Essex CCGs, issuing mobile ECG devices to 82% of practices across the CCGs, resulting in 23 new patients identified with possible AF and 431 additional patients receiving anticoagulation treatment.

The way someone uses their phone may indicate if they are about to have a mental health relapse, as researchers supported by UCLPartners are finding out.

The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision.

A team from Moorfields Eye Hospital and UCL have found that laser-based treatment is more successful and cost-effective than standard treatments on newly diagnosed cases of glaucoma.

Psychiatric researchers at UCL are working with the Metropolitan Police and local branches of mental health charity Mind, to trial a new intervention aimed at reducing the distressing psychological outcomes, known to be prevalent among older victims of crime.

A ‘first of its kind’ online tool developed by researchers at UCL, which allows people with type 2 diabetes to better manage their condition, is being trialled across the NHS.

In 2016, Professor Amit Nathwani of UCL and the Royal Free Hospital, was awarded the European Society for Gene and Cell Therapy’s Outstanding Achievement Award for his pioneering work on gene therapy for Haemophilia.

A team led by clinician scientists Professors Bobby Gaspar and Adrian Thrasher at Great Ormond Street Hospital NHS Trust and UCL have pioneered the use of gene therapy for rare diseases in children.